PGF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Protagonist Therapeutics Inc

Watchlist Manager

Watchlist

Price: 75 EUR Market Closed

Market Cap: €2.9B

P	Protagonist Therapeutics Inc XBER:PGF	US
	Barratt Developments P L C LSE:BDEV	UK
R	Realty Income Corp XMUN:RY6	US
	Zscaler Inc F:0ZC	US
A	Auckland International Airport Ltd F:BZTA	NZ
B	Banca Popolare Di Sondrio SpA DUS:593	IT
	First Commonwealth Financial Corp NYSE:FCF	US
J	JCDecaux SE XMUN:DCS	FR
	Element Fleet Management Corp F:61F	CA
P	Pitney Bowes Inc DUS:PBW	US
	AngloGold Ashanti Ltd F:AOD1	ZA
	Beauty Health Co F:V7A0	US

Profitability Summary

Protagonist Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-192%

Negative 3Y Average Operating Margin

-46%

Negative Net Margin

-155%

Negative 3Y Average Net Margin

-27%

Negative Free Cash Flow Margin

-159%

Strong 3Y Average Free Cash Flow Margin

Negative 3Y Average ROIC

-257%

ROIC is Increasing

-1.494% > -93%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.